BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.14% | -8.03% | -11.36% | -- | -- |
| Total Depreciation and Amortization | 5.26% | 5.56% | 3.09% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.89% | -53.90% | -57.98% | -- | -- |
| Change in Net Operating Assets | 472.39% | 254.31% | 66.56% | -- | -- |
| Cash from Operations | -20.29% | -23.66% | -37.90% | -- | -- |
| Capital Expenditure | -583.58% | -410.97% | -120.48% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -70,019.40% | -50,450.97% | -37.59% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | -140.00% | -500.00% | -- | -- |
| Issuance of Common Stock | 51,608.16% | 3,174,900.00% | 5,556,225.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -99.68% | -99.68% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.84% | -808.02% | -8,782.54% | -- | -- |
| Cash from Financing | 29.18% | 17.97% | 990.98% | -- | -- |
| Foreign Exchange rate Adjustments | 175.00% | 61.29% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.51% | -41.17% | 12,358.73% | -- | -- |